| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Haskins Laboratories, Pace University, New York, NY 10038, USA
2 Department of Chemistry and Physical Sciences, Pace University, New York, NY 10038, USA
3 Laboratory of Molecular and Cellular Parasitology and Infectious Disease Programme, Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore
Correspondence
Nigel Yarlett
nyarlett{at}pace.edu
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Present address: The University of Moscow Medical School, Moscow, Russia.
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
; Lee, 1991) and has been reported to cause intestinal disease in a number of cases, resulting in abdominal cramps, diarrhoea and significant discomfort (Weg et al., 1987). In some cases the parasite has been reported to cause acute illness (Russo et al., 1988; Vannatta et al., 1985) and can be life threatening when present in immunocompromised individuals (Prasad et al., 2000). Endoscopic and permeability studies of the intestine in a cohort study of Blastocystis-infected immunocompetent individuals failed to find any significant intestinal inflammation or impairment of the intestinal permeability barrier (Zuckerman et al., 1994). Fresh Blastocystis isolates, though, have been demonstrated to cause significant cytopathology of Chinese hamster ovary cells (CHO), adenocarcinoma HT-29 cells and rat intestinal epithelia (IEC-6) cells in culture (Puthia et al., 2006; Walderich et al., 1998). Metronidazole, paromomycin and ketoconazole have been used as therapeutic agents with mixed success (Zierdt et al., 1983; Dunn & Boreham, 1991; Haresh et al., 1999; Nanba et al., 2003). Although there have been some advances made concerning the morphology and cytochemistry of the organism, little is known of the biochemistry. The presence of mitochondrion-like organelles (MLO) has been inferred, based largely upon microscopic evidence (Zierdt et al., 1988); however, key mitochondrial proteins such as Krebs cycle enzymes and cytochromes were not detected (Zierdt, 1986; Zierdt et al., 1988). These studies were hampered by difficulties in obtaining large amounts of the organism and problems associated with obtaining pure organelles such as MLO, which tend to clump upon fractionation (Zierdt et al., 1988). Nasirudeen & Tan (2004) described a method for the isolation of MLO from this organism and observed the presence of DNA in the organelles.
Adaptation to anaerobic environments has resulted in the evolution of modified energy-generating organelles, such as hydrogenosomes in the trichomonads (Lindmark & Müller, 1973, 1974), rumen protists (Yarlett et al., 1981), rumen fungi (Yarlett et al., 1986) and protists inhabiting the cockroach hind gut (Akhmanova et al., 1998). Other recently described modified mitochondria include the mitosome of Entamoeba (Tovar et al., 1999), the cryptic organelle of Giardia sp. (Marti et al., 2003), the relict organelle in Cryptosporidium parvum (Keithly et al., 2005) and the microsporidians Antonospora locustae and Encephalitozoon cuniculi (Burri et al., 2006). These organelles have one or more of the following features in common with the mitochondrion – recognition of specific targeting sequences (Dacks et al., 2006), production of ATP (Embley et al., 2003; van Weelden et al., 2005) and iron–sulfur cluster assembly (Tachezy et al., 2001) – leading to the suggestion that these organelles all arose from a common ancestor. In this study we demonstrate the presence of key mitochondrial enzymes in Blastocystis and show they are localized in organelles previously described as MLO.
|
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
) or subtype 7 (Stensvold et al., 2007) in later phylogenetic or terminology standardization studies, respectively, was used. The parasite was grown in 10 ml pre-reduced Iscove's modified Dulbecco's medium (IMDM) supplemented with 10 % heat-inactivated horse serum. Cultures were incubated for 48 h in anaerobic jars using an Oxoid AneroGen pack at 37 °C. Two-day-old cultures were centrifuged at 1600 g for 10 min, washed once in a buffer consisting of 30 mM potassium phosphate, 74 mM NaCl, 0.6 mM CaCl2 and 1.6 mM KCl, pH 7.4 and resuspended in 50 mM Tris/HCl (pH 7.2).
Fractionation.
Cells were broken under a stream of nitrogen gas by 40 strokes in a 10 ml Potter–Elvehjem tissue homogenizer at 4 °C in an isotonic buffer consisting of 200 mM sucrose (pH 7.2) containing 30 mM phosphate, 15 mM mercaptoethanol, 30 mM NaCl, 0.6 mM CaCl2, and 0.6 mM KCl. The broken cells were diluted with isotonic buffer that had been degassed under vacuum and the air replaced with nitrogen before centrifugation at 500 g for 10 min using a Sorvall RC-2B. The supernatant was further fractionated by centrifugation to give a large granular fraction (5000 g for 10 min), a small granular fraction (25 000 g for 20 min) and a final supernatant. Density gradients were prepared from 15 and 65 % (w/w) sucrose in 10 mM Tris/HCl buffer (pH 7.2), containing 0.7 mM EDTA and 15 mM mercaptoethanol. The large granular fraction (4 mg protein) and the small granular fraction (2 mg protein) were carefully layered on top of the gradients and centrifuged in a 6x12 ml swing-out rotor (Beckman OTD 65 ultracentrifuge) at 4 °C for 30 min at 46 000 g. Fractions (approx. 2 ml) from the gradient were collected under nitrogen and assayed immediately for enzyme activity. The density of the fractions was determined using a refractometer.
Enzyme analysis
Unless stated otherwise, enzyme assays were performed under anaerobic conditions using buffers, substrates and cofactors that had the air removed under vacuum and replaced with nitrogen. Cuvette additions were made in an anerobic chamber (Coy Laboratories) and Blastocystis protein (40–60 µg) was added to start the reaction by injection through a rubber septum.
(a) Enzymes characteristic of hydrogenosomes.
With the exception of formate dehydrogenase, assays performed for these enzymes used 40 µg Trichomonas vaginalis protein obtained as described by Lindmark & Müller (1973), as a positive control. Hydrogenase (EC 1.12.7.2) and pyruvate : ferredoxin oxidoreductase (PFOR; EC 1.2.7.1) were assayed by measuring the change in absorbance at 600 nm due to the reduction of methyl viologen [extinction coefficient (
)=8.25 mM–1cm–1] as described by Lindmark & Müller (1973). Hydrogenase was assayed using 100 mM potassium phosphate (pH 7.4), 20 mM methyl viologen and 250 mM 2-mercaptoethanol under a stream of hydrogen. PFOR was assayed using 100 mM potassium phosphate (pH 7.4), 20 mM methyl viologen, 250 mM 2-mercaptoethanol, 0.1 % Triton X-100, 0.25 mM coenzyme A (CoA) and 2.5 mM pyruvate. Malic enzyme (EC 1.1.1.40) was assayed using the method of Lindmark & Müller (1974) in 6 mM triethanolamine (pH 6.8), 1 mM NADP+, 0.66 mM MnCl2 and 0.1 % Triton X-100. The reaction was started by the injection of 33 mM malate through a rubber septum and the change in absorbance at 340 nm ( NADP+=6.3 mM–1 cm–1) measured. Succinate thiokinase (STK; EC 6.2.1.5) was assayed as described by Lindmark & Müller (1974) in Tris/succinate buffer (pH 7.4), 0.1 mM MgCl2, 1 mM CoA and 1 mM ATP. The reaction was started by the addition of protein and the change in absorbance at 235 nm ( ATP=40 mM–1 cm–1) compared to controls lacking ATP. Formate dehydrogenase (EC 1.2.1.2) was determined by the method of Nanba et al. (2003). The assay contained 40 mM phosphate buffer (pH 7.2), 0.5 mM sodium formate (pH 7.0), 5 mM NAD+, and protein to start the reaction. The absorbance change at 340 nm ( NAD+=6.3 mM–1 cm–1) was recorded for 10 min at 30 °C.
(b) Enzymes characteristic of mitochondria.
With the exception of pyruvate : NADP+ 2-oxidoreductase (PNO), assays for this group of enzymes used 30 µg rat liver homogenate (Fansler & Lowenstein, 1969) as a positive control. PNO (EC 1.2.1.51) was determined in the forward direction using the method of Inui et al. (1987). The assay consisted of 100 mM potassium phosphate (pH 7.4), 2.5 mM pyruvate, CoA, 1 mM NADP+. The change in absorbance at 340 nm was measured at 37 °C for 10 min ( NAD+=6.3 mM–1 cm–1). The activity of PNO was also determined by replacing NADP+ with 1 mM FAD+ ( FAD+=11.7 mM–1 cm–1 at 446 nm), 1 mM FMN+ ( FMN+=12.5 mM–1 cm–1 at 450 nm), 0.5–5.0 mM NAD+ ( NAD+=6.3 mM–1 cm–1 at 340 nm), 0.1–1.0 mg Clostridium pasteurianum ferredoxin ( 4Fe–4S ferredoxin=17.6 mM–1 cm–1 at 390 nm) or 0.1–1.0 mg Spinacia oleracea ferredoxin ( 2Fe–2S ferredoxin=10.8 mM–1 cm–1 at 425 nm) as electron acceptor. Citrate synthase (EC 2.3.3.1) was assayed under aerobic conditions as described by Parvin (1969) using 2.5 mM 5,5'-dithiobis-2-nitrobenzoic acid (DTNB) dissolved in 20 mM Tris/HCl (pH 8.0) as indicator ( DTNB=13.6 mM–1 cm–1 at 414 nm). The reaction contained 0.1 M Tris (pH 8.0), 0.25 mM DTNB, 0.2 mM oxaloacetate, 0.1 mM acetyl-CoA and Blastocystis protein. The change in absorbance was monitored at 414 nm for 10 min. Aconitase (EC 4.2.1.3) was determined by the method of Fansler & Lowenstein (1969). The homogenate was activated by incubation under nitrogen for 30 min at 30 °C with a 1 : 1 mixture of protein and 10 mM thiomalate containing 2 mM ferrous ammonium sulfate in Tris (pH 7.8), previously made anaerobic. The assay contained 20 mM Tris (pH 7.6), 50 mM NaCl, 2 mM cis-aconitate, and protein in a final volume of 1 ml. The change in absorbance was recorded at 240 nm ( cis-aconitate=3.5 mM–1 cm–1) for 15 min at 37 °C. Isocitrate dehydrogenase NADP+ (EC 1.1.1.42) was assayed using the coupled assay described by Cook & Sanwal (1969). The assay contained 0.16 M Tris/acetate (pH 7.6), 0.18 mM dichlorophenolindophenol (=34.2 mM–1 cm–1 at 600 nm), 0.5 mM NADP+, 0.27 mM AMP, 0.83 mM isocitrate (pH 7.6) and protein to start the reaction. Blanks lacking enzyme were subtracted from the rate. The decrease in absorbance at 600 nm was measured for 10 min. 
-Ketoglutarate dehydrogenase (EC 1.2.4.2) was assayed as described by Sanadi (1969), and contained 60 mM phosphate buffer (pH 7.6), 0.10 mM CoA, 35 mM cysteine (pH 7.0), 0.35 mM NAD+ (=6.3 mM–1 cm–1) and 0.5 mM -ketoglutarate. The absorbance change at 340 nm was monitored for 10 min after the addition of protein. Acetate : succinate CoA transferase (ASCT; EC 2.8.3.8) activity was using the radioactive method described by Van Hellemond et al. (1998), in a mixture containing 50 mM succinate (pH 7.4), 1 mM [1-14C]acetyl-CoA (0.2 MBq), 50 mM Tris/HCl (pH 7.4), 10 mM MgCl2 and 0.05 % (v/v) Triton X-100. The reaction was started by the addition of protein and incubated for 20 min at 30 °C. The reaction was stopped with 10 % trichloracetic acid and cooled on ice. The [1-14C]acetate was separated by HPLC using a reverse-phase C-18 Percosil column (4.6x250 mm), 10 µm particle size (Perkin Elmer), with a linear gradient starting with 80 % 0.1 M NaH2PO4 (pH 3.25) containing 8 mM octanesulfonic acid changing to 100 % 0.1 M NaH2PO4 (pH 5.5) containing 8 mM octanesulfonic acid and 75 % (v/v) methanol in 30 min. Signals were recorded and integrated using a β-Ram model-2 radiometric detector (IN/US Inc.). Malate dehydrogenase (EC 1.1.1.37) was assayed by measuring the decrease in absorbance at 340 nm due to NADH oxidation ( NAD+=6.3 mM–1 cm–1) with oxaloacetate. The assay contained 50 mM triethanolamine.HCl (pH 7.4), 5 mM EDTA, 0.12 mM oxaloacetate (pH 7.0), 0.15 mM NADH, and was started by addition of protein (Englard, 1969). Fumarate hydratase (EC 4.2.1.2) was assayed under aerobic conditions as described by Genda et al. (2006) in 100 mM phosphate buffer (pH 7.6), 50 mM malate and protein to start the reaction. The absorbance change at 250 nm (=1.45 mM–1 cm–1) was monitored for 10 min. Succinate dehydrogenase (EC 1.3.99.1) was assayed using 3.8 mM dichlorophenolindophenol (=34.2 mM–1 cm–1 at 600 nm), 50 mM phenazine methosulfate, 20 mM KCN, in 100 mM potassium phosphate buffer (pH 7.4), and protein (Singer & Kearney, 1963). Sodium succinate (200 mM) was added to start the reaction and the absorbance at 600 nm monitored for 10 min at 37 °C.
(c) Cytosolic enzymes.
Assays for this group of enzymes used 40 µg of T. vaginalis protein obtained as described by Lindmark & Müller (1973), as a positive control. Glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12) was assayed by measuring the change in absorption at 340 nm due to the reduction of 0.5 mM NAD+ (=6.3 mM–1 cm–1) with 0.1 mM glyceraldehyde 3-phosphate in 0.14 mM phosphate buffer (pH 7.6) (Duggleby & Dennis, 1974). Lactate dehydrogenase (EC 1.1.1.27) was assayed as described by Yarlett et al. (1986) using 25 mM phosphate buffer (pH 7.4), 0.1 mM NADH (=6.3 mM–1 cm–1), 0.5 mM pyruvate (pH 7.0). The absorbance change at 340 nm was monitored for 10 min. Phosphoenolpyruvate carboxykinase (PEPCK; EC 4.1.1.32) activity was determined under aerobic conditions by the method of Fukuda et al. (2004) using 50 mM NaHCO3, 5 mM MnCl2, 10 mM phosphoenolpyruvate (PEP), and 2 mM GDP in 100 mM imidazole buffer (pH 7.2). The reaction was started by addition of protein and incubated at 37 °C for 30 min, stopped by addition of 50 mM EDTA and cooled to 4 °C. The oxaloacetate formed was determined by measuring the absorbance change at 340 nm due to the addition of 0.2 mM NADH (=6.3 mM–1 cm–1) and 3 units of yeast malate dehydrogenase in 100 mM imidazole buffer (pH 7.2). Pyruvate kinase (EC 2.7.1.40) was assayed under aerobic conditions by measuring the ATP produced from ADP (0.1 mM) in 80 mM triethanolamine buffer (pH 7.5) containing 1.3 mM EDTA, 2.0 mM MgSO4 and 1.0 mM PEP. Protein was added to start the reaction and the ATP formed after 15 min was quantified using a luminometer and 0.1 mg firefly luciferase (Boyer, 1962).
(d) Enzymes characteristic of lysosomes.
Assays for this group of enzymes used 30 µg rat liver homogenate (Fansler & Lowenstein, 1969) as a positive control. -Galactosidase (EC 3.2.1.22) was assayed under aerobic conditions by measuring the hydrolysis of 0.1 mg o-nitrophenyl -D-galactopyranoside ( for p-nitrophenol at 400 nm=17.5 mM–1 cm–1) in 0.1 M acetate buffer (pH 4.5) and protein for 10 min at 37 °C. The reaction was stopped using 1 ml 1 M borate (pH 10) and the absorbance at 420 nm recorded (Borooah et al., 1961). -Mannosidase (EC 3.2.1.24) was determined under aerobic conditions using a fluorescent assay containing 10 mM 4-methylumbelliferyl -D-mannopyranoside in 25 mM sodium acetate (pH 4.0) and protein for 10 min at 37 °C. The assay was stopped with 2 ml 0.25 M glycine/KOH (pH 10.3) and the fluorescence determined using an excitation wavelength of 355 nm and an emission wavelength of 460 nm and compared to a 4-methylumbelliferone standard (Prence & Natowicz, 1992).
Protein determination.
Protein was determined by the Lowry method.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
). Malic enzyme was detected using NADP+ as electron acceptor with a specific activity consistent with that found in other organisms (Lindmark et al., 1989; Yarlett et al., 1981). The activity of this and other NAD+- and NADP+-utilizing enzymes was consistently higher when assayed under anaerobic conditions (described in Methods) due to recycling of the reduced nucleotide by NADH/NADPH oxidase. The activity of NAD+- and NADP+-utilizing enzymes presented in Table 1 were therefore determined under an oxygen-free atmosphere. The activity of an enzyme converting pyruvate to acetyl-CoA was detected in Blastocystis extracts using NADP+ as an electron acceptor. The enzyme was characterized based upon substrate and cofactor requirements to be PNO (EC 1.2.1.51). The Blastocystis PNO could use FAD+ (5 mM) or FMN+ (5 mM) as an electron acceptor at 30 % and 74 %, respectively, of the rate observed with NADP+ (1 mM). The enzyme was, however, inactive using 0.5–5.0 mM NAD+, 0.1–1.0 mg Clostridium pasteurianum (4Fe–4S) or 0.1–1.0 mg Spinacia oleracea (2Fe–2S) ferredoxin as electron acceptor. The enzyme was 100 % inhibited by incubation under a stream of air for 5 min, and 60 % inhibited by incubation under a stream of CO2 for 5 min compared to controls measured under N2. The enzyme activity could also be determined using methyl viologen as electron acceptor, which resulted in 30 % of the activity obtained using 0.1 mM NADP+. The acetyl-CoA formed by PNO was converted to acetate by ASCT (EC 2.8.3.8). The activity of the Blastocystis ASCT was confirmed using extracts of the procyclic stage of Trypanosoma brucei brucei as positive control. The presence of some of the enzymes characteristic of the Krebs cycle were determined using whole-cell extracts of Blastocystis and compared to a rat liver homogenate as a positive control. Citrate synthase (EC 2.3.3.1) and succinate dehydrogenase (EC 1.3.99.1) were not detected using a pH range of 5.7–7.6 (limits of detection 2 nmol min–1). However, other Krebs cycle enzymes were present at levels comparable to control cells; aconitase (EC 4.2.1.3), isocitrate dehydrogenase (EC 1.1.1.42), -ketoglutarate dehydrogenase (EC 1.2.4.2), STK (EC 6.2.1.5), fumarate hydratase (EC 4.2.1.2) (Table 1), enabling construction of a partial pathway leading from the conversion of citrate to succinyl-CoA (Fig. 1).
|
|
). Integrity of organelles was confirmed by latency of enzyme activities using 2 % Triton X-100. Malic enzyme, PNO and ASCT had 60 %, 92 % and 83 % increased activity with the addition of Triton X-100. Based upon the ratio of the specific activity of the enzyme in the fraction to that in the homogenate (relative specific activity), it was concluded that malic enzyme, PNO, ASCT, STK, -ketoglutarate dehydrogenase, isocitrate dehydrogenase and aconitase localized to the large granular fraction (Fig. 2A–G), whereas PEPCK, malate dehydrogenase, fumarate hydratase, pyruvate kinase and lactate dehydrogenase localized to the non-sedimentable fraction (Fig. 2H–L). -Galactosidase and -mannosidase activity were detected in the small granular fraction which is typical of lysosomes (Fig. 2M, N). Isopycnic gradient centrifugation of the large granular fraction and assay of the enzymes malic enzyme, PNO, ASCT, STK, -ketoglutarate dehydrogenase, isocitrate dehydrogenase and aconitase localized to a band having a density of 1.20 g ml–1 (Fig. 3A), which is the same density as that reported for hydrogenosomes and mitochondria (Hart & Opperdoes, 1984; Woods et al., 1988). Isopycnic gradient centrifugation of the small granular fraction and assay of -galactosidase and -mannosidase resulted in these enzymes localizing to a band having a density of 1.16 g ml–1 (Fig. 3B), typical of lysosomal organelles (Hart & Opperdoes, 1984; Woods et al., 1988).
|
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
) and Cryptosporidium parvum (Rotte et al., 2001). These biochemical findings are in agreement with a search of the Blastocystis EST database (http://pepdbpub.bcm.umontreal.ca/pathway//BH/server.html) that reveals the presence of a gene with 77 % sequence identity to the PNO mitochondrion precursor cluster from E. gracilis sp[Q941N5] (accession number BHL00002376). The PNO gene from E. gracilis is believed to have arisen through fusion of a eubacterial gene for PFOR with the gene for NADPH cytochrome p450 reductase (Rotte et al., 2001). In agreement with these findings, a second cluster with 56 % sequence identity to the PFOR cluster typical of T. vaginalis (accession number BHL00001771) was also found, although activity of this enzyme could not be demonstrated. In common with other PNOs, the enzyme was oxygen sensitive, being completely inactivated when cell-free extracts were exposed to air. The Blastocystis PNO was capable of transferring electrons to FAD+ or FMN+ at 30 % and 74 %, respectively, of the rate observed with NADP+; several other electron acceptors, including NAD+ and Clostridium or spinach ferredoxin, were inactive. In hydrogenosomes the electron acceptor is a 2 iron : 2 sulfur ferredoxin (Gorrell et al., 1984), whereas in mitochondria the electrons are transferred from the NADH to the cytochrome chain, resulting in the formation of ATP (Krayl et al., 2007). The electron transport proteins in Blastocystis are unknown, but may be similar to the NADPH : cytochrome p450 reductase in Euglena and Cryptosporidium parvum (Rotte et al., 2001) or the flavoprotein : rhodoquinone complex as described in the anaerobic mitochondria of parasitic nematodes (Ma et al., 1993). The efficacy of metronidazole in the treatment of Blastocystis infections indicates the presence of low-potential electron-acceptor proteins in this parasite. Typically, metronidazole reduction involves the transfer of electrons from pyruvate by the action of PFOR (Edwards, 1993). The ability of PNO to reduce metronidazole has not been definitively demonstrated but the enzyme may function in this capacity. It has been demonstrated that the electrons for metronidazole activation by T. vaginalis can originate from malate which is oxidatively decarboxylated by malic enzyme (Hrdy et al., 2005). The electrons released from malate reduce NAD+ and are subsequently transferred to ferredoxin by the NADH : ferredoxin oxidoreductase activity of the NADH dehydrogenase module of mitochondrial respiratory complex I (Hrdy et al., 2004). Future studies will be aimed at identifying the terminal electron acceptor involved in metronidazole reduction by Blastocystis.
The presence of ASCT and STK results in the formation of acetate and ATP. In addition, an incomplete Krebs cycle was detected that results in the formation of succinyl-CoA. The proposed metabolic pathway (Fig. 1) retains key features of typical mitochondria and hydrogenosomes that couple the energy of the thioester bond of CoA to the generation of ATP. The inability to detect Krebs cycle enzymes in earlier seminal studies of Blastocystis by C. H. Zierdt (Zierdt, 1986; Zierdt et al., 1988) that paved the way for these and other studies of this parasite may be due to oxygen inactivation of enzymes involved in the pathway during processing of homogenates.
In common with other anaerobic protists (Lindmark et al., 1989), the fumarate hydratase of Blastocystis is of low activity and localized solely in the cytosol. There are two distinct classes of fumarate hydratase. Class I enzymes are of -proteobacterial origin and include fumA and fumB; these are homodimeric, thermolabile, iron–sulfur enzymes with a molecular mass of 120 kDa (Woods et al., 1988; Gerbod et al., 2001). Class II enzymes are of archaeal origin (fumC) and are homotetrameric, thermostable, iron-independent enzymes with a molecular mass of 200 kDa (Colombo et al., 1994; Gerbod et al., 2001). They are both present in eukaryotic cells, but are differentially localized with class I fumarate hydratase present in the mitochondria (Woods et al., 1988), whereas class II enzymes are localized in the cytosol (Suzuki et al., 1989). It is unknown what type of fumarate hydratase is present in Blastocystis, but a search of the Blastocystis database (http://pepdbpub.bcm.umontreal.ca/pathway//BH/server.html) reveals the presence of several genes with homology to both class I fumarate hydratases (accession numbers BHL00001095, BHL00001685, BHL00001701) and class II fumarate hydratases (accession numbers BHL00001811, BHL00001165). The Trichomonas fetus fumarate hydratase has been shown to be of the class II type, leading to the suggestion that they have a different origin from those of mitochondria-containing cells (Gerbod et al., 2001).
The transformation of energy-rich substrates such as glucose to metabolic end products involves multiple steps that can vary considerably between different organisms. However, there are certain key points that are common to all, such as the steps involving electron transfer and the conservation of high-energy bonds for the ultimate formation of ATP. To this end a significant metabolic feature of the proposed pathway in the Blastocystis MLO is the transformation of pyruvate to acetate and the conservation of the high-energy thioester bond to form ATP. In common with trichomonad and Neocallimastix hydrogenosomes (Steinbuchel & Müller, 1986; Yarlett et al., 1986), and mitochondria from the promastigote Leishmania mexicana, Leishmania infantum, Phytomonas sp. and procyclic Trypanaosoma brucei, as well as the parasitic helminth Fasciola hepatica (Van Hellemond et al., 1998), Blastocystis utilizes a two-step mechanism that couples succinate : succinyl CoA cycling with acetate formation to conserve the energy of the thioester bond to drive subcellular ATP formation (Fig. 1). This finding is consistent with the proposed common origin of hydrogenosomes and mitochondria (Martin, 1999). The absence of detectable succinate dehydrogenase activity suggests that the primary function of the partial Krebs cycle in Blastocystis is to provide precursors for the synthesis of amino acids or acetyl-CoA for fatty acid biosynthesis as occurs in E. gracilis (Hoffmeister et al., 2005). The presence of a partial Krebs cycle has been reported in the mitochondria from procyclic Trypanosoma brucei (Van Hellemond et al., 2005; van Weelden et al., 2005), which is proposed to function to export acetyl-CoA to the cytoplasm for fatty acid biosynthesis. The enzyme transferring the CoA moiety from acetyl-CoA to succinate in T. vaginalis hydrogenosomes is ASCT, which has been identified in the T. vaginalis genome (van Grinsven et al., 2008). The enzyme has high similarity to Saccharomyces cerevisiae acetyl-CoA hydrolase and Clostridium kluyveri succinyl-CoA : CoA-transferase (van Grinsven et al., 2008). A BLAST search (http://tbestdb.bcm.umontreal.ca/searches/login.php) of the Blastocystis database using the ASCT sequence from T. vaginalis G3 (EST DS113258) reveals the presence of a protein with 78 % identity (BHL 00000444) to the T. vaginalis protein.
The adaptability of the mitochondrion is evident from the literature and we therefore conclude that, despite the lack of cytochromes or other identifiable electron-transport proteins, the organelle from Blastocystis, which is characterized as a DNA-containing, double-membrane-bound structure with a partial Krebs cycle and an active ATP-generating metabolism, is best described as an MLO.
|
ACKNOWLEDGEMENTS |
|---|
Edited by: J. Tachezy
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Borooah, J., Leaback, D. H. & Walker, P. G. (1961). Studies on glucosaminidase. 2. Substrates for N-acetyl-β-glucosaminidase. Biochem J 78, 106–110.[Medline]
Boyer, P. D. (1962). Pyruvate kinase. In The Enzymes, pp. 95–113. Edited by P. D. Boyer, K. H. Lardy & K. Myrback. New York: Academic Press.
Burri, L., Williams, B. A., Bursac, D., Lithgow, T. & Keeling, P. J. (2006). Microsporidia mitosomes retain elements of the general mitochondrial targeting system. Proc Natl Acad Sci U S A 103, 15916–15920.
Colombo, S., Grisa, M., Tortora, P. & Vanoni, M. (1994). Molecular cloning, nucleotide sequence and expression of a Sulfolobus solfataricus gene encoding a class II fumarase. FEBS Lett 337, 93–98.[CrossRef][Medline]
Cook, R. A. & Sanwal, B. D. (1969). Isocitrate dehydrogenase (NAD-specific) from Neurospora crassa. Methods Enzymol 13, 42–47.[Medline]
Dacks, J. B., Dyall, P. L., Embley, T. M. & van der Giezen, M. (2006). Hydrogenosomal succinyl-CoA synthetase from the rumen-dwelling fungus Neocallimastix patriciarum; an energy-producing enzyme of mitochondrial origin. Gene 373, 75–82.[CrossRef][Medline]
Duggleby, R. G. & Dennis, D. T. (1974). Nicotinamide adenine dinucleotide-specific glyceraldehyde 3-phosphate dehydrogenase from Pisum sativum. J Biol Chem 249, 167–174.
Dunn, L. A. & Boreham, P. F. (1991). The in vitro activity of drugs against Blastocystis hominis. J Antimicrob Chemother 27, 507–516.
Edwards, D. I. (1993). Nitroimidazole drugs-action and resistance mechanisms. II. Mechanisms of resistance. J Antimicrob Chemother 31, 201–210.
Embley, T. M., van der Giezen, M., Horner, D. S., Dyal, P. S. & Foster, P. (2003). Mitochondria and hydrogenosomes are two forms of the same fundamental organelle. Philos Trans R Soc Lond B Biol Sci 358, 191–201.
Englard, S. (1969). Extramitochondrial L-malate dehydrogenase of beef heart. Methods Enzymol 13, 123–129.[CrossRef]
Fansler, B. & Lowenstein, J. M. (1969). Aconitase from pig heart. Methods Enzymol 13, 26–30.[CrossRef]
Fukuda, W., Fukui, T., Atomi, H. & Imanaka, T. (2004). First characterization of an archaeal GTP-dependent phosphoenolpyruvate carboxykinase from the hyperthermophilic archaeon Thermococcus kodakaraensis KOD1. J Bacteriol 186, 4620–4627.
Genda, T., Watabe, S. & Ozaki, H. (2006). Purification and characterization from Corynebacterium glutamicum. Biosci Biotechnol Biochem 70, 1102–1109.[CrossRef][Medline]
Gerbod, D., Edgcomb, V. P., Noël, C., Vanacova, S., Wintjens, R., Tachezy, J., Sogin, M. L. & Viscogliosi, E. (2001). Phylogenetic relationships of class II fumarase genes from trichomonads. Mol Biol Evol 18, 1574–1584.
Gorrell, T. E., Yarlett, N. & Müller, M. (1984). Isolation and characterization of Trichomonas vaginalis ferredoxin. Carlsberg Res Commun 49, 259–268.[CrossRef]
Haresh, K., Suresh, K., Khairul Anus, A. & Saminathan, S. (1999). Isolate resistance of Blastocystis hominis to metronidazole. Trop Med Int Health 4, 274–277.[CrossRef][Medline]
Hart, D. T. & Opperdoes, F. R. (1984). The occurrence of glycosomes (microbodies) in the promastigote stage of four major Leishmania species. Mol Biochem Parasitol 13, 159–172.[CrossRef][Medline]
Hoffmeister, M., Piotrowski, M., Nowitzki, U. & Martin, W. (2005). Mitochondrial trans-2-enoyl-CoA reductase of wax ester fermentation from Euglena gracilis defines a new family of enzymes involved in lipid synthesis. J Biol Chem 280, 4329–4338.
Hrdy, I., Hirt, R. P., Dolezal, P., Bardonova, L., Foster, P. G., Tachezy, J. & Embley, T. M. (2004). Trichomonas hydrogenosomes contain the NADH dehydrogenase module of mitochondrial complex I. Nature 432, 618–622.[CrossRef][Medline]
Hrdy, I., Cammack, R., Stopka, P., Kulda, J. & Tachezy, J. (2005). Alternative pathway of metronidazole activation in Trichomonas vaginalis hydrogenosomes. Antimicrob Agents Chemother 49, 5033–5036.
Inui, H., Ono, K., Miyatake, K., Nakano, Y. & Kitaoka, S. (1987). Purification and characterization of pyruvate : NADP+ oxidoreductase in Euglena gracilis. J Biol Chem 262, 9130–9135.
Keithly, J. S., Langreth, S. G., Buttle, K. F. & Mannella, C. A. (2005). Electron tomographic and ultrastructural analysis of the Cryptosporidium parvum relict mitochondrion, its associated membranes, and organelles. J Eukaryot Microbiol 52, 132–140.[CrossRef][Medline]
Krayl, M., Lim, J. H., Martin, F., Guiard, B. & Voos, W. (2007). A cooperative action of the ATP-dependent import motor complex and the inner membrane potential drives mitochondrial preprotein import. Mol Cell Biol 27, 411–425.
Lavier, G. (1952). Blastocystis spp. Ann Parasitol Hum Comp 27, 339–356.[Medline]
Lee, M. J. (1991). Pathogenicity of Blastocystis hominis. J Clin Microbiol 29, 2089
Lindmark, D. G. & Müller, M. (1973). Hydrogenosome, a cytoplasmic organelle of the anaerobic flagellate Tritrichomonas foetus, and its role in pyruvate metabolism. J Biol Chem 248, 7724–7728.
Lindmark, D. G. & Müller, M. (1974). Biochemical cytology of anaerobic flagellates. II. Subcellular distribution of oxidoreductases and hydrolases in Monocercomonas sp. J Protozool 21, 374–378.[Medline]
Lindmark, D. G., Eckenrode, B. L., Halberg, L. A. & Dinbergs, I. D. (1989). Carbohydrate, energy and hydrogenosomal metabolism of Tritrichomonas foetus and Trichomonas vaginalis. J Protozool 36, 214–216.[Medline]
Ma, Y.-C., Funk, M., Dunham, W. R. & Komuniecki, R. (1993). Purification and characterization of electron-transfer flavoprotein : rhodoquinone oxidoreductase from anaerobic mitochondria of the adult parasitic nematode Ascaris suum. J Biol Chem 268, 20360–20365.
Marti, M., Regos, A., Li, Y., Schraner, E. M., Wild, P., Muller, N., Knopf, L. G. & Hehl, A. B. (2003). An ancestral secretory apparatus in the protozoan parasite Giardia intestinalis. J Biol Chem 278, 24837–24848.
Martin, W. (1999). A briefly argued case that mitochondria and plastids are descendents of endosymbionts, but that the nuclear compartment is not. Proc Biol Sci 266, 1387–1395.
Nanba, H., Takaoka, Y. & Hasegawa, J. (2003). Purification and characterization of formate dehydrogenase from Ancylobacter aquaticus strain KNK607M, and cloning of the gene. Biosci Biotechnol Biochem 67, 720–728.[CrossRef][Medline]
Nasirudeen, A. M. & Tan, K. S. (2004). Isolation and characterization of the mitochondrion-like organelle from Blastocystis hominis. J Microbiol Methods 58, 101–109.[CrossRef][Medline]
Noël, C., Dufernez, F., Gerbod, D., Edgcomb, V. P., Delgado-Viscogliosi, P., Ho, L. C., Singh, M., Wintjens, R., Sogin, M. L. & other authors (2005). Molecular phylogenies of Blastocystis isolates from different hosts: implications for genetic diversity, identification of species, and zoonosis. J Clin Microbiol 43, 348–355.
Parvin, R. (1969). Citrate synthase from yeast. Methods Enzymol 13, 16–19.[Medline]
Prasad, K. N., Nag, V. L., Dhole, T. N. & Ayyagari, A. (2000). Identification of enteric pathogens in HIV-positive patients with diarrhea in northern India. J Health Popul Nutr 18, 23–26.[Medline]
Prence, E. M. & Natowicz, M. R. (1992). Diagnosis of alpha mannosidosis by measuring alpha mannosidase in plasma. Clin Chem 38, 501–503.
Puthia, M. K., Sio, S. W., Lu, J. & Tan, K. S. (2006). Blastocystis ratti induces contact-independent apoptosis, F-actin rearrangement, and barrier function disruption in IEC-6 cells. Infect Immun 74, 4114–4123.
Rotte, C., Stejskal, F., Zhu, G., Keithly, J. S. & Martin, W. (2001). Pyruvate : NADP+ oxidoreductase from the mitochondrion of Euglena gracilis and from the apicomplexan Cryptosporidium parvum: a biochemical relic linking pyruvate metabolism in mitochondriate and amitochondriate protists. Mol Biol Evol 18, 710–720.
Russo, A. R., Stone, S. L., Taplin, M. E., Snapper, H. J. & Doern, G. V. (1988). Presumptive evidence for Blastocystis hominis as a cause of colitis. Arch Intern Med 148, 1064
Sanadi, D. R. (1969). -Ketoglutarate dehydrogenase from pig heart. Methods Enzymol 13, 52–55.[CrossRef]
Singer, T. P. & Kearney, E. B. (1963). Succinate dehydrogenase. In The Enzymes, pp. 383–445. Edited by P. D. Boyer, K. H. Lardy & K. Myrback. New York: Academic Press.
Steinbuchel, A. & Müller, M. (1986). Anaerobic pyruvate metabolism of Tritrichomonas foetus and Trichomonas vaginalis hydrogenosomes. Mol Biochem Parasitol 20, 57–65.[CrossRef][Medline]
Stensvold, C. R., Suresh, G. K., Tan, K. S., Thompson, R. C., Traub, R. J., Viscogliosi, E., Yoshikawa, H. & Clark, C. G. (2007). Terminology for Blastocystis subtypes – a consensus. Trends Parasitol 23, 93–96.[CrossRef][Medline]
Suzuki, T., Sato, M., Yoshida, T. & Tuboi, S. (1989). Rat liver mitochondrial and cytosolic fumarases with identical amino acid sequences are encoded from a single gene. J Biol Chem 264, 2581–2586.
Tachezy, J., Sanchez, L. B. & Müller, M. (2001). Mitochondrial type iron-sulfur cluster assembly in the amitochondriate eukaryotes Trichomonas vaginalis and Giardia intestinalis, as indicated by the phylogeny of IscS. Mol Biol Evol 18, 1919–1928.
Tovar, J., Fischer, A. & Clark, C. G. (1999). The mitosome, a novel organelle related to mitochondria in the amitochondrial parasite Entamoeba histolytica. Mol Microbiol 32, 1013–1021.[CrossRef][Medline]
van Grinsven, K. W., Rosnowsky, S., van Weelden, S. W., Pütz, S., van der Giezen, M., Martin, W., van Hellemond, J. J., Tielens, A. G. & Henze, K. (2008). Acetate : succinate CoA-transferase in the hydrogenosomes of Trichomonas vaginalis: identification and characterization. J Biol Chem 283, 1411–1418.
Van Hellemond, J. J., Opperdoes, F. R. & Tielens, A. G. (1998). Trypanosomatidae produce acetate via a mitochondrial acetate : succinate CoA transferase. Proc Natl Acad Sci U S A 95, 3036–3041.
Van Hellemond, J. J., Opperdoes, F. R. & Tielens, A. G. (2005). The extraordinary mitochondrion and unusual citric acid cycle in Trypanosoma brucei. Biochem Soc Trans 33, 967–971.[CrossRef][Medline]
van Weelden, S. W. H., van Hellemond, J. J., Opperdoes, F. R. & Tielens, A. G. M. (2005). New functions for parts of the krebs cycle in procyclic Trypanosoma brucei, a cycle not operating as a cycle. J Biol Chem 280, 12451–12460.
Vannatta, J. B., Adamson, D. & Mullican, K. (1985). Blastocystis hominis infection presenting as recurrent diarrhea. Ann Intern Med 102, 495–496.
Walderich, B., Bernauer, S., Renner, M., Knobloch, J. & Burchard, G. D. (1998). Cytopathic effects of Blastocystis hominis on Chinese hamster ovary (CHO) and adenocarcinoma HT29 cell cultures. Trop Med Int Health 3, 385–390.[CrossRef][Medline]
Weg, A. L., Soave, R. & Jacobson, I. M. (1987). The significance of intestinal Blastocystis hominis infection. Gastroenterology 92, 1688
Woods, S. A., Schwartzbach, S. D. & Guest, J. D. (1988). Two biochemically distinct classes of fumarase in Escherichia coli. Biochim Biophys Acta 954, 14–26.[CrossRef][Medline]
Yarlett, N., Hann, A. C., Lloyd, D. & Williams, A. G. (1981). Hydrogenosomes in the rumen protozoan Dasytricha ruminantium Schuberg. Biochem J 200, 365–372.[Medline]
Yarlett, N., Orpin, C. G., Munn, E. A., Yarlett, N. C. & Greenwood, C. A. (1986). Hydrogenosomes in the rumen fungus Neocallimastix patriciarum. Biochem J 236, 729–739.[Medline]
Zierdt, C. H. (1986). Cytochrome free mitochondria of an anaerobic protozoan – Blastocystis hominis. J Protozool 33, 67–69.[Medline]
Zierdt, C. H., Swan, J. C. & Hosseini, J. (1983). In vitro response of Blastocystis hominis to antiprotozoal drugs. J Protozool 30, 332–334.[Medline]
Zierdt, C. H., Donnolley, C. T., Muller, J. & Constantopoulos, G. (1988). Biochemical and ultrastructural study of Blastocystis hominis. J Clin Microbiol 26, 965–970.
Zuckerman, M. J., Watts, M. T., Ho, H. & Meriano, F. V. (1994). Blastocystis hominis infection and intestinal injury. Am J Med Sci 308, 96–101.[Medline]
Received 22 February 2008;
revised 10 April 2008;
accepted 14 April 2008.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
